ArticleHematology reports2024

The Cardiovascular Event Risk Associated with Tyrosine Kinase Inhibitors and the Lipid Profile in Patients with Chronic Myeloid Leukemia.

María Nieves Saez Perdomo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.